RGEN

REPLIGEN CORP

Biological Products, (No Diagnostic Substances)NasdaqLarge accelerated filer

Total Trades

48

Buys

6

Sells

27

Largest Trade

$1M+

Insiders

12

Institutional Funds

399

Inst. Value

$1M+

Activist Filings

19

Insider Trades

InsiderTitleTypeValueSharesPriceDate
DAWES KAREN ADirectorSELL$15K–$50K275$161.00Dec 18, 2025
Loeillot OlivierCEOSELL$1M+7K$170.00Nov 26, 2025
Bylund JamesCOOSELL$100K–$500K2K$151.21Nov 19, 2025
Hunt AnthonyDirectorSELL$1M+20K$154.61Nov 14, 2025
Hunt AnthonyDirectorEXERCISE$50K–$100K3K$33.87Nov 14, 2025
Hunt AnthonyDirectorEXERCISE$500K+25K$33.87Nov 13, 2025
Hunt AnthonyDirectorSELL$1M+25K$156.88Nov 13, 2025
Hunt AnthonyDirectorEXERCISE$500K+20K$33.87Sep 11, 2025
Hunt AnthonyDirectorSELL$1M+29K$120.52Sep 11, 2025
Hunt AnthonyDirectorSELL$1M+26K$123.71May 16, 2025
Hunt AnthonyDirectorSELL$1M+27K$152.51Mar 19, 2025
Hunt AnthonyDirectorEXERCISE$1M+27K$54.73Mar 19, 2025
Pax MargaretDirectorBUY$15K–$50K250$150.69Mar 18, 2025
Hunt AnthonyDirectorEXERCISE$500K+24K$33.87Nov 22, 2024
Hunt AnthonyDirectorSELL$1M+24K$139.67Nov 22, 2024
KURIYEL RALFSenior VP, R&DSELL$500K+4K$165.67Aug 2, 2024
Madaus Martin DDirectorBUY$100K–$500K2K$124.94Jun 14, 2024
BARTHELEMY NICOLASDirectorBUY$100K–$500K1K$125.45Jun 14, 2024
Hunt AnthonyCEOBUY$100K–$500K2K$124.08Jun 14, 2024
Hunt AnthonyCEOSELL$1M+20K$168.26May 22, 2024
DAWES KAREN ADirectorEXERCISE$100K–$500K5K$42.07Feb 29, 2024
DAWES KAREN ADirectorSELL$100K–$500K1K$193.35Feb 29, 2024
Bylund JamesCOOEXERCISE$50K–$100K940$94.33Feb 27, 2024
Bylund JamesCOOSELL$500K+4K$198.08Feb 27, 2024
Gebski ChristineSee RemarksSELL$500K+4K$147.13Nov 13, 2023
DAWES KAREN ADirectorSELL$100K–$500K850$171.38Aug 30, 2023
DAWES KAREN ADirectorEXERCISE$100K–$500K7K$18.12Aug 30, 2023
Madaus Martin DDirectorBUY$100K–$500K2K$158.84May 9, 2023
Snodgres JonCFOSELL$1M+6K$200.00Feb 17, 2023
EGLINTON MANNER CARRIEDirectorBUY$100K–$500K625$175.02Dec 15, 2022
Hunt AnthonyCEOEXERCISE$500K+25K$33.87Nov 14, 2022
Hunt AnthonyCEOSELL$1M+25K$200.00Nov 14, 2022
DAWES KAREN ADirectorSELL$100K–$500K775$227.17Sep 9, 2022
Hunt AnthonyCEOSELL$1M+26K$224.73Sep 9, 2022
Hunt AnthonyCEOEXERCISE$100K–$500K10K$33.87Sep 9, 2022
Snodgres JonCFOSELL$1M+7K$252.86Aug 17, 2022
Snodgres JonCFOEXERCISE$100K–$500K4K$117.37Aug 17, 2022
KURIYEL RALFSenior VP, R&DSELL$1M+5K$254.32Aug 12, 2022
KURIYEL RALFSenior VP, R&DEXERCISE$100K–$500K4K$50.58Aug 12, 2022
Gebski ChristineSee RemarksSELL$500K+3K$243.01Aug 5, 2022
Bylund JamesCOOEXERCISE$100K–$500K2K$94.33Aug 4, 2022
Bylund JamesCOOSELL$100K–$500K2K$240.40Aug 4, 2022
Snodgres JonCFOSELL$100K–$500K2K$220.00Aug 2, 2022
Hunt AnthonyCEOSELL$1M+25K$200.00Jul 22, 2022
Hunt AnthonyCEOEXERCISE$500K+20K$32.76Jul 22, 2022
DAWES KAREN ADirectorSELL$1M+15K$150.51May 26, 2022
RYAN THOMAS F JRDirectorSELL$100K–$500K2K$198.03Mar 3, 2022
RYAN THOMAS F JRDirectorEXERCISE$15K–$50K1K$38.76Mar 3, 2022
🔓Seeing ranges? Sign in for exact trade values — free forever

Activist & 5%+ Owners

SC 13D/13G filings — investors holding 5%+ of outstanding shares

Roy T. Eddleman Living Trust

SC 13G/A · Feb 13, 2026

4.8%

2.7M shares

FMR LLC

SC 13G · Feb 5, 2026

5.1%

2.9M shares

T. Rowe Price Associates, Inc.

SC 13G/A · Sep 8, 2025

6.1%

3.4M shares

BlackRock, Inc.

SC 13G/A · Apr 24, 2025

9.3%

5.2M shares

T. Rowe Price Associates, Inc.

SC 13G/A · Feb 14, 2025

12.7%

7.1M shares

Roy T. Eddleman Living Trust

SC 13G/A · Feb 13, 2025

4.8%

2.7M shares

11.4%

6.4M shares

BlackRock, Inc.

SC 13G/A · Nov 12, 2024

12.7%

7.1M shares

BlackRock, Inc.

SC 13G/A · Oct 23, 2024

12.7%

7.1M shares

10.9%

6.1M shares

7.2%

4.0M shares

The Vanguard Group - 23-1945930

SC 13G/A · Feb 13, 2024

9.1%

5.1M shares

BlackRock, Inc.

SC 13G/A · Jan 23, 2024

14.1%

7.9M shares

4.9%

0.271 shares

9.1%

5.1M shares

BlackRock, Inc.

SC 13G/A · Jan 23, 2023

11.0%

6.1M shares

BlackRock, Inc.

SC 13G · Sep 8, 2022

10.2%

5.7M shares

5.5%

3.0M shares

BlackRock, Inc.

SC 13G/A · Jan 31, 2022

9.4%

5.2M shares

View on Google Finance →